MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 1 filers reported holding MEDICINES CO in Q4 2008. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $66,000 | 0.0% | 784 | 0.0% | 0.00% | – |
Q4 2019 | $66,000 | -71.6% | 784 | -83.1% | 0.00% | -100.0% |
Q3 2019 | $232,000 | +43.2% | 4,645 | +4.0% | 0.00% | 0.0% |
Q2 2019 | $162,000 | +1146.2% | 4,465 | +836.1% | 0.00% | – |
Q1 2019 | $13,000 | +44.4% | 477 | 0.0% | 0.00% | – |
Q4 2018 | $9,000 | -35.7% | 477 | +29.3% | 0.00% | – |
Q2 2018 | $14,000 | +55.6% | 369 | +3.4% | 0.00% | – |
Q1 2018 | $9,000 | 0.0% | 357 | 0.0% | 0.00% | – |
Q4 2017 | $9,000 | +50.0% | 357 | +95.1% | 0.00% | – |
Q3 2017 | $6,000 | -25.0% | 183 | 0.0% | 0.00% | – |
Q2 2017 | $8,000 | 0.0% | 183 | 0.0% | 0.00% | – |
Q1 2017 | $8,000 | -11.1% | 183 | -45.7% | 0.00% | – |
Q1 2016 | $9,000 | 0.0% | 337 | +30.6% | 0.00% | – |
Q4 2015 | $9,000 | 0.0% | 258 | 0.0% | 0.00% | – |
Q3 2015 | $9,000 | +200.0% | 258 | +61.2% | 0.00% | – |
Q2 2015 | $3,000 | -99.2% | 160 | -98.5% | 0.00% | -100.0% |
Q4 2013 | $398,000 | +15.0% | 10,326 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $346,000 | +9.1% | 10,326 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $317,000 | -7.8% | 10,326 | 0.0% | 0.00% | -86.7% |
Q1 2013 | $344,000 | -67.0% | 10,326 | -74.5% | 0.03% | -73.7% |
Q3 2012 | $1,044,000 | +48.5% | 40,450 | +23.4% | 0.11% | +200.0% |
Q1 2012 | $703,000 | +151.1% | 32,780 | +117.5% | 0.04% | -2.6% |
Q4 2011 | $280,000 | +1.1% | 15,070 | -19.1% | 0.04% | -15.2% |
Q3 2011 | $277,000 | -9.8% | 18,637 | 0.0% | 0.05% | +7.0% |
Q2 2011 | $307,000 | +16.7% | 18,637 | 0.0% | 0.04% | -4.4% |
Q4 2010 | $263,000 | -21.3% | 18,637 | -20.9% | 0.04% | -29.7% |
Q3 2010 | $334,000 | +86.6% | 23,566 | 0.0% | 0.06% | +68.4% |
Q2 2010 | $179,000 | -39.9% | 23,566 | -13.0% | 0.04% | -37.7% |
Q3 2009 | $298,000 | +31.3% | 27,099 | 0.0% | 0.06% | +15.1% |
Q2 2009 | $227,000 | +42.8% | 27,099 | +84.2% | 0.05% | +17.8% |
Q1 2009 | $159,000 | -26.4% | 14,712 | 0.0% | 0.04% | -18.2% |
Q4 2008 | $216,000 | -36.7% | 14,712 | 0.0% | 0.06% | -16.7% |
Q3 2008 | $341,000 | +17.2% | 14,712 | 0.0% | 0.07% | +29.4% |
Q2 2008 | $291,000 | +98.0% | 14,712 | +217.1% | 0.05% | +104.0% |
Q4 2007 | $147,000 | -40.5% | 4,640 | -53.1% | 0.02% | -35.9% |
Q1 2007 | $247,000 | +68.0% | 9,885 | +113.0% | 0.04% | +56.0% |
Q4 2006 | $147,000 | – | 4,640 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |